Physician Assistant · Augusta, GA
NPI
1043548399
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1120 15th St
Augusta, GA, 30912
Phone (706) 721-4581
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,502
189 services
Medicare patients, 2024
61
Average age 61
Drug cost, 2024
$4.3M
1,464 prescriptions
Company payments, 2025
$104
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca J Rahn was code 99215 (office e&m - established), 64 times for 48 patients. In total Rebecca J Rahn billed 189 services in 9 codes, and Medicare paid $7,502.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 64 | 48 | $78.38 | $5,016 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 44 | 41 | $9.85 | $433 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 32 | 20 | $17.91 | $573 |
By year: 2023 $9,872 for 134 services; 2024 $7,502 for 189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca J Rahn prescribed most often to Medicare patients was Kesimpta Pen (Ofatumumab), with 131 prescriptions and refills. In total Rebecca J Rahn wrote 1,464 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kesimpta Pen Ofatumumab | 131 | 131 | 17 | $1.2M |
| Baclofen Generic | 111 | 275 | 46 | $3,445 |
| Gabapentin Generic | 97 | 176 | 34 | $1,702 |
| Pregabalin Generic | 59 | 100 | 16 | $2,303 |
| Fingolimod Fingolimod Hcl | 55 | 67 | Under 11 | $22K |
| Tizanidine Hcl Generic | 52 | 74 | 16 | $1,498 |
| Escitalopram Oxalate Generic | 49 | 97 | 12 | $341 |
| Ocrevus Ocrelizumab | 43 | 242 | 23 | $1.6M |
| Teriflunomide Generic | 42 | 48 | Under 11 | $38K |
| Clonazepam Generic | 40 | 42 | Under 11 | $331 |
| Dimethyl Fumarate Generic | 39 | 45 | Under 11 | $21K |
| Tecfidera Dimethyl Fumarate | 33 | 33 | Under 11 | $289K |
| Linzess Linaclotide | 29 | 47 | Under 11 | $25K |
| Zeposia Ozanimod Hydrochloride | 29 | 37 | Under 11 | $329K |
| Levetiracetam Generic | 28 | 62 | Under 11 | $829 |
Brand drugs: 440 claims; generic drugs: 1,024 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca J Rahn $104 ($104 in general payments such as food, travel and fees) from 3 companies. The largest payer was EMD Serono, Inc. with $57.95.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.